An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Alltrna, a clinical‑stage biotech, seeks a Sr. Principal Scientist / Director of DMPK & Bioanalytical Sciences to lead DMPK and bioanalytical strategy across nonclinical and clinical programs in a fast‑paced environment.
This hands‑on role drives PK/PD study design, assay development, and translational biomarker strategy with CRO oversight. The candidate will author regulatory sections, supervise scientists, and collaborate with pharmacology teams to integrate data across portfolios and support
Cambridge, MA USA
Reporting to the Chief Scientific Officer, this role leads DMPK and bioanalytical strategy across nonclinical and clinical programs, operating as a hands‑on scientific leader. We are looking for an accomplished DMPK and bioanalytical scientist with experience in PK study design, bioanalytical method development, and translational biomarker strategy. This person will support pharmacology and nonclinical toxicology programs, providing broader context across the nonclinical development portfolio. The ideal candidate brings deep scientific expertise and a hands‑on approach and thrives in the fast‑paced environment of a clinical‑stage biotech where both scientific and strategic contributions are expected.
Alltrna is the first clinical‑stage biotech company advancing tRNA medicines to address shared disease‑causing mutations across many indications. The company’s initial therapeutic programs are designed to restore full‑length protein production in diseases caused by premature termination codons (PTCs), collectively referred to as Stop Codon Disease, which affects approximately 10% of people with a rare genetic disease. Alltrna’s lead program, AP003, is a chemically modified, engineered tRNA oligonucleotide encapsulated in a clinically validated, liver‑directed lipid nanoparticle. AP003 is being developed for the arginine‑to‑TGA (Arg‑TGA) PTC in patients with liver Stop Codon Disease, including phenylketonuria, organic acidemias, and urea cycle disorders. Founded in 2018 by Flagship Pioneering, Alltrna has built an integrated platform to design, optimize, and deliver engineered tRNA therapeutics.
The salary range for this role is $179,000 – $236,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Alltrna currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Alltrna's good faith estimate as of the date of publication and may be modified in the future.
When you apply for a role at Flagship Pioneering or one of its portfolio companies, we collect and use personal information you provide (such as your name, contact details, work history, and application materials) to evaluate your application, communicate with you, and comply with legal obligations. Your application data is processed through Greenhouse, our applicant tracking system, and may also be reviewed using AI‑assisted screening tools. We do not sell your personal information. California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information. If you are located in the EU or UK, we process your data under GDPR and you have rights to access, rectify, and erase your data. To exercise your rights or for questions, contact privacy@flagshippioneering.com.